A AstraZeneca PLC
| Market Cap | $315.47B |
| P/E Ratio | 31.16 |
| Forward P/E | 34.12 |
| Dividend Yield | 1.55% |
| Beta | 0.28 |
| 52W Range | $127.51 - $208.62 |
| # Hedge Funds | 3 |
| Sector | Healthcare |
| Industry | Drug Manufacturers - General |
Hedge Fund Ownership
| Investor 3 | % of Portfolio Weight of this stock in the investor's portfolio | Value Total dollar value of the position | Shares Number of shares held | Activity Portfolio change type: New, Increased, Decreased, or Sold |
|---|---|---|---|---|
| Sarah Ketterer Causeway Capital Management | 1.28% | $92.93M | 1,010,898 | Reduce 5.29% |
| Bill Nygren Harris Associates LP | 0.43% | $342.87M | 3,729,731 | Buy |
| Dodge & Cox Dodge & Cox | 0.01% | $11.13M | 121,043 | Reduce 11.96% |
Frequently Asked Questions
What is AZN stock price today?
AstraZeneca PLC (AZN) is currently trading at $203.49. The stock has a 52-week range of $127.51 to $208.62 and a market capitalization of $315.47B.
Is AZN a good stock to buy in 2026?
AstraZeneca PLC has a P/E ratio of 31.2 (forward P/E: 34.1), a dividend yield of 1.55%, and 1-year performance of +40.0%. 3 hedge funds hold this stock. Review the fundamentals and ownership data above to make an informed decision.
Are insiders buying or selling AZN stock?
There have been 0 insider transactions for AZN in recent months. Insider buys can signal management confidence, while sales may reflect diversification or personal financial planning. Check the Insider Trading section above for details.
How has AZN stock performed over the past year?
AstraZeneca PLC (AZN) has returned +40.0% over the past 12 months. The stock traded between $127.51 and $208.62 during this period, and is currently at $203.49.
Which hedge funds own AZN (AstraZeneca PLC)?
3 tracked hedge funds currently hold AZN in their portfolios as of the latest 13F filings. See the ownership table above for the complete list.
What is AZN's market cap and valuation?
AstraZeneca PLC (AZN) has a market capitalization of $315.47B. The trailing P/E ratio is 31.2 and forward P/E is 34.1. The stock is classified in the Healthcare sector.
What is AZN's revenue and profitability?
AstraZeneca PLC reported revenue of $58.74B with net income of $10.23B and a profit margin of 0.17%. The stock has a beta of 0.28.
What sector is AZN in and who are its biggest institutional holders?
AstraZeneca PLC (AZN) operates in the Healthcare sector. It is held by 3 tracked hedge funds. See the ownership table above for the complete list.